Neumora Therapeutics, Inc. (NMRA)
NASDAQ:NMRA
US Market
Holding NMRA?
Track your performance easily

Neumora Therapeutics, Inc. (NMRA) Ownership - Who Owns Neumora Therapeutics, Inc.?

135 Followers

Neumora Therapeutics, Inc. (NMRA) Ownership Overview

66.24%6.79%2.45%5.23%19.29%
66.24% Insiders
2.45% Other Institutional Investors
5.23% ETFs
19.29% Public Companies and
Individual Investors
The ownership structure of Neumora Therapeutics, Inc. (NMRA) stock is a mix of institutional, retail, and individual investors. Approximately 14.47% of the company’s stock is owned by Institutional Investors, 66.24% is owned by Insiders, and 19.29% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 15, 2023
Kristina Burow
Director, >10% Owner
xxxxxxxxxxxxx
$412140
Nov 15, 2023
xxxxxxxxxxxxx
$412140
Nov 13, 2023
Kristina Burow
Director, >10% Owner
xxxxxxxxxxxxx
$1543563
Nov 13, 2023
xxxxxxxxxxxxx
$1543563

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$1126459
Jun 30, 2024
xxxxxxxxxxxxx
$1613692
Jun 30, 2024
xxxxxxxxxxxxx
$10170118

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
31,979,855Insider19.98%380,880,073
31,932,138Insider19.95%380,311,764
31,932,138Insider19.95%380,311,764
7,984,147Insider5.20%95,091,191
4,115,279Institution2.57%49,012,973
3,242,720Institution2.03%38,620,795
2,636,488Institution1.65%31,400,572
1,488,504Institution0.93%17,728,083
1,034,600Institution0.65%12,322,086
934,597Institution0.58%11,131,050

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,636,488Institution1.65%31,400,572
1,488,504Institution0.93%17,728,083
934,597Institution0.58%11,131,050
906,310Institution0.57%10,794,152
902,400Institution0.56%10,747,584
838,065Institution0.52%9,981,354
722,300Institution0.45%8,602,593
459,800Institution0.29%5,476,218
453,783Institution0.28%5,404,556
426,277Institution0.27%5,076,959

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,393,040Institution1.50%31,612,058
2,159,838Institution1.35%25,291,703
1,251,355Institution0.78%16,530,400
746,573Institution0.47%8,742,370
385,101Institution0.24%5,087,184
404,899Institution0.25%4,522,722
207,882Institution0.13%2,434,298
120,102Institution0.08%1,406,394
106,664Institution0.07%1,191,437
100,239Institution0.06%1,173,799

FAQ

Who Owns Neumora Therapeutics, Inc. (NMRA)?
According to the latest TipRanks data, approximately 2.45% of the company's stock is held by institutional investors, 66.24% is held by insiders, and 19.29% is held by retail investors.
    What percentage of Neumora Therapeutics, Inc. (NMRA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 2.45% of Neumora Therapeutics, Inc. (NMRA) stock is held by institutional investors.
      What percentage of Neumora Therapeutics, Inc. (NMRA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 19.29% of Neumora Therapeutics, Inc. (NMRA) stock is held by retail investors.
        Who owns the most shares of Neumora Therapeutics, Inc. (NMRA)?
        Kristina Burow owns the most shares of Neumora Therapeutics, Inc. (NMRA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis